




|
NATURAL IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUSES: PROSPECTS FOR AIDS VACCINES
Omar Bagasra and Muhammad Amjad
The Dorrance H. Hamilton Laboratories, Section of Molecular Retrovirology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical Collage, Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Suite 329, Philadelphia, PA 19107
Received 6/18/97, Accepted 7/22/97
TABLE OF CONTENTS
1. Abstract
-
2. Introduction
-
3. The retroviruses and their ability to integrate into the host genome
-
4. What immune mechanisms are responsible for inhibiting retroviral replication: a new hypothesis
-
5. Scientific basis for current vaccines
-
5.1. Development of vaccine based on humoral immunity
-
5.2. Development of vaccine based on cell-mediated immunity
-
6. Anomalous observations with retroviral infections: is there "molecular immunity"?
-
6.1. Epidemiological studies
-
7. Other evidence for " molecular immunity": no manifestation of disease with other lentiviral infection
-
8. "Molecular immunity" needed to be explained
-
9. Role of CD8+ cell in the development of anti-retroviral immunity
-
10. Are beta-chemokines the answer for CD8+ cell factors?
-
11. Some cofactors can compromise Immunity
-
12. Factors which interfere in the anti-retroviral "molecular immunity" pathways
-
13. Two outcome scenarios
-
14. The twelve steps of molecular immunity
-
15. Acknowledgments
-
16. References
17. Entire manuscript
Keywords: HIV-1, AIDS, Retrovirus, Vaccine, CD8+, Lymphocyte, Chemokines, Molecular immunity
Search OMIM (Online Mendelian Inheritance in Man) to find related articles
This form requires a WWW Client such as Netscape, XMosaic, Lynx that supports fill-in forms.
|